Don't Jump to Spiriva First-Line for Mild COPD
New evidence will spark controversy over how to treat COPD patients with MILD disease.
About seven in 10 COPD patients have early disease with minimal symptoms. But meds are usually studied in moderate to severe COPD.
Now evidence suggests that Spiriva (tiotropium), a long-acting muscarinic antagonist (LAMA), may be beneficial for mild COPD.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote